Transplantation of Human Organs and Tissues Rules, 2025

Mandatory Equipment Removed: A Step Forward or a Misstep in Corneal Transplant Accessibility?

The Union Ministry of Health and Family Welfare made a decisive move on November 11, 2025—removing the mandatory requirement for Clinical Specular Microscope equipment in corneal transplantation centers through amendments to the Transplantation of Human Organs and Tissues Rules, 2025. This equipment, which assesses corneal endothelial cell health, had been a barrier for smaller hospitals and rural centers aiming to expand eye care services. At first glance, the reform appears aligned with the government’s broader healthcare equity goals, but it opens up critical questions about the balance between accessibility and clinical standards.

A Policy Framework Built on the 1994 Act

The amendment roots itself in the regulatory architecture of the Transplantation of Human Organs and Tissues Act, 1994. While this Act primarily focused on organ transplantation to combat illicit organ trade, subsequent updates have broadened its scope to tissue transplantation, including cornea donation. The rules now connect to the National Organ Transplant Programme (NOTP), tasked with ensuring equitable access to critical transplant services across India. NOTP remains heavily centralized, with funding channelled directly to states via the Ministry of Health. However, annual budgetary allocations remain insufficient—₹125 crore for NOTP in 2025 compared to the estimated ₹500 crore required to heavily scale activities.

India faces a staggering deficit in corneal donations. Although around 50,000 cornea replacements occur annually, this pales next to the estimated 1.2 million corneal blind citizens. Add to this, the yearly burden—25,000 to 30,000 new cases—and the inadequacy of current interventions becomes painfully evident. The cornea sector’s infrastructure consists of a limited number of transplant centers concentrated in urban hubs, exacerbating inequalities in healthcare access.

By removing mandatory equipment requirements, the Ministry hopes to lower entry barriers for smaller centers in under-resourced regions. Yet, one must ask whether this level of deregulation curtails clinical oversight—a trade-off that could undermine the quality of transplants and postoperative outcomes.

The Numbers Behind Corneal Blindness—and Their Implications

India’s demographic challenge cannot be overstated. With 12 million blind or visually impaired individuals, corneal blindness is the second-leading cause among those over 50 years of age, trailing only cataracts. Efforts at reducing this burden have largely failed because of logistical gaps: insufficient tissue banks, a lack of skilled ophthalmologists, and weak institutional coordination. Consider this: according to the government’s own data, tissue banks often operate at under 25% capacity due to limited retrieval mechanisms and bureaucratic hurdles.

The amendment’s direct aim—boosting cornea donations—is inherently tied to systems of coordination among hospitals, tissue banks, and regulatory bodies. While the removal of the Clinical Specular Microscope requirement will increase registrations for new centers, two weaknesses persist. First, the absence of the equipment risks improper donor tissue selection, potentially harming recipient outcomes. Second, coordination gaps among state health departments and private medical institutions could impede efforts to match donors with receivers efficiently.

The irony here is not lost: in prioritizing accessibility at the cost of rigorous oversight, are we eroding the very standards that should define transplant success?

Lessons from International Models: The South Korean Case

South Korea’s cornea donation system presents an intriguing counterpoint. Governed under a rigorously enforced Organ Transplant Act, South Korea mandates equipment standards even in regional hospitals but pairs this with government subsidies for compliance. Equipment like the Clinical Specular Microscope is not a hurdle for hospitals because the institutional financing model bridges the gap. Notably, South Korea allocates over US$200 million annually for organ and tissue donation infrastructure—a figure five times India’s budget.

India’s decentralization model, though theoretically empowering states, contrasts sharply with the centralized South Korean approach. The latter not only ensures stringent clinical standards but also fosters uniform access across urban and rural facilities. Without similar financial commitments in India, the removal of mandatory equipment risks exacerbating rural-urban healthcare disparities.

Structural Tensions: Accessibility vs Oversight

At the heart of this reform lies a fundamental tension: how does the government balance expanded access for rural populations with the imperative for clinical quality? The Ministry's decision to remove the Clinical Specular Microscope from mandatory requirements highlights a policy leaning towards “good enough” standards rather than global best practices.

Beyond technical barriers, the deeper issue lies in institutional coordination. State health departments operate independently when setting budgets for corneal transplant centers, often leading to uneven infrastructure development. For instance, Tamil Nadu’s tissue banks boast surplus capacity compared to Bihar’s centers, which struggle with donor registrations. Much of this stems from central schemes imposing broad compliance mandates but allowing minimal discretionary spending by states—a governance flaw that mirrors India’s broader healthcare policy inequities.

Additionally, the reliance on private players for cornea donations and transplants remains under-regulated. Private hospitals dominate urban markets but are rarely inspected rigorously, even after multiple revisions to rules. This undermines accountability mechanisms, particularly for high-stakes surgeries like corneal transplants.

The Road Ahead and Metrics of Success

Success for this amendment would mean not just more registered corneal transplant centers but demonstrable improvements in outcomes—fewer cases of transplant rejection, higher donor tissue retrieval rates, and equitable geographic distribution of cornea surgeries. Tracking these metrics must form the backbone of future policy assessments.

On ground implementation, however, remains key. Much depends on whether state governments allocate sufficient funds for equipping transplant centers with trained clinicians, despite the loosened infrastructure requirements. And this assumes cornea donation drives themselves gain momentum—a difficult proposition given that India’s donation rate remains abysmally low at 1.2 donations per million population.

Finally, the amendment’s true success will hinge on its ability to strike a balance between accessibility and clinical rigor. Without clear accountability systems, India risks creating a patchwork system where clinical quality varies widely by geography.

Exam-oriented Integration

Prelims MCQs:

• Which section of the Transplantation of Human Organs and Tissues Act, 1994 governs tissue donations?
  (a) Section 4A
  (b) Section 9
  (c) Section 11
  (d) Section 14
  Answer: (c)
• What was the primary purpose of removing the mandatory Clinical Specular Microscope requirement?
  (a) Ensuring uniform technical oversight
  (b) Expanding accessibility for rural centers
  (c) Improving transplant standards
  (d) Reducing state coordination gaps
  Answer: (b)

Mains Question:

Critically evaluate whether the 2025 amendments to the Transplantation of Human Organs and Tissues Rules effectively address India’s corneal blindness burden. Assess the structural limitations embedded in the country’s organ donation ecosystem.

Practice Questions for UPSC

Prelims Practice Questions

Frequently Asked Questions